Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock
February 21, 2025 16:05 ET | Source: Intelligent Bio Solutions, Inc. NEW…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH,…
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nations Health and Prosperity
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio…
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's…
Belite Bio Announces Registered Direct Offering of $15 Million
February 05, 2025 22:35 ET | Source: Belite Bio, Inc SAN DIEGO,…
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
- Dr. Doebele has over 15 years of oncology drug development experience…
Annovis Bio, Inc. Announces Proposed Public Offering
MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis…
Cabaletta Bio to Participate in Guggenheims SMID Cap Biotech Conference
January 29, 2025 08:00 ET | Source: Cabaletta Bio PHILADELPHIA, Jan. 29,…
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…